CLINICAL TRIALS PROFILE FOR SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

All Clinical Trials for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01928082 ↗	The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass	Terminated	University of Chicago	Phase 2	2013-08-01	The purpose of this study is to assess if estrogen replacement normalizes urinary calcium excretion in postmenopausal women with hypercalciuria and low bone mass and to assess for differences in response to estrogen replacement in women with familial hypercalciuria compared to nonfamilial hypercalciuria.
NCT02124447 ↗	Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy	Withdrawn	Medical College of Wisconsin	N/A	2014-06-01	This will be a 4-way comparison to prospectively evaluate the efficacy and patient tolerability of four commercially available bowel preparations among patients undergoing colonoscopy for screening and surveillance in a single tertiary academic medical center.
NCT02523911 ↗	Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening	Withdrawn	Mercy Medical Center, Des Moines, Iowa	N/A	2016-03-01	The purpose of this study is to investigate Suprep bowel preparation, with and without the anti-gas medication simethicone, in terms of efficacy and patient tolerability in the preparation of patients undergoing routine colonoscopy for colorectal cancer screening.
NCT02523911 ↗	Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening	Withdrawn	MercyOne Des Moines Medical Center	N/A	2016-03-01	The purpose of this study is to investigate Suprep bowel preparation, with and without the anti-gas medication simethicone, in terms of efficacy and patient tolerability in the preparation of patients undergoing routine colonoscopy for colorectal cancer screening.
NCT03299452 ↗	Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor	Unknown status	Alphacait, LLC	Phase 2	2017-01-01	This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
NCT03299452 ↗	Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor	Unknown status	Haining Health-Coming Biotech Co., Ltd.	Phase 2	2017-01-01	This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor.
NCT04225793 ↗	The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing Colonoscopy	Recruiting	Russian Society of Colorectal Surgeons	N/A	2019-06-02	The gold standard of colorectal examination is colonoscopy. One of the main purposes of colonoscopy is detecting bowel neoplasms. Right now there are several methods the bowel preparation for the colonoscopy. Several factors can affect the quality of the bowel preparation, such as the kind of oral laxative, the time after its intake and the diet followed in the days before colonoscopy. In this randomized clinical trial the investigators aimed to compare the safety and efficiency of two low-volume laxatives for bowel preparation: potassium, magnesium and sodium sulphates-based laxative Eziclen (IPSEN, France) and Macrogol-3350 + Sodium Sulfate + Potassium Chloride+ Sodium Chloride + Ascorbic Acid-based and Sodium Ascorbate-based Moviprep (Nordgine B.V., The Netherlands)

Clinical Trial Conditions for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate

Condition Name

Condition Name for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Intervention	Trials
Colorectal Disorders	1
Hypercalciuria	1
Hypercalciuria, Familial Idiopathic	1
Kidney Stones	1

Condition MeSH

Condition MeSH for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Intervention	Trials
Colonic Diseases	1
Neoplasm Metastasis	1
Colorectal Neoplasms	1
Osteoporosis	1

Clinical Trial Locations for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate

Trials by Country

Trials by Country for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Location	Trials
United States	5
China	3
Russian Federation	1
Egypt	1

Trials by US State

Trials by US State for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Location	Trials
Utah	1
Iowa	1
Florida	1
Wisconsin	1
Illinois	1

Clinical Trial Progress for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate

Clinical Trial Phase

Clinical Trial Phase for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Clinical Trial Phase	Trials
PHASE1	1
Phase 4	1
Phase 3	2

Clinical Trial Status

Clinical Trial Status for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Clinical Trial Phase	Trials
Not yet recruiting	3
Withdrawn	2
Recruiting	2

Clinical Trial Sponsors for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate

Sponsor Name

Sponsor Name for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Sponsor	Trials
Hebei Provincial People's Hospital	1
Daewoong Pharmaceutical Co. LTD.	1
MercyOne Des Moines Medical Center	1

Sponsor Type

Sponsor Type for Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate
Sponsor	Trials
Other	25
Industry	2

Clinical Trials Update, Market Analysis, and Projection for Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate

Last updated: January 27, 2026

Summary

This report provides a comprehensive update on clinical trials, market dynamics, and future projections for sodium sulfate, potassium sulfate, and magnesium sulfate. These inorganic salts have widespread industrial, pharmaceutical, and agricultural applications. The analysis covers recent clinical developments, market size, growth drivers, competitive landscape, regulatory environment, and future trends.

---

Clinical Trials Landscape

Overview of Clinical Trials

Currently, clinical trials involving sulfate salts mainly focus on medical and pharmaceutical applications, particularly as excipients, laxatives, or in novel drug delivery systems. Notably, magnesium sulfate is well-documented in obstetrics and neurology, while potassium sulfate’s clinical research revolves around electrolyte management.

Parameter	Data
Total relevant trials (clinicaltrials.gov, as of Q1 2023)	42 trials (magnesium sulfate: 28, potassium sulfate: 9, sodium sulfate: 5)
Status of trials	60% completed, 30% recruiting, 10% withdrawn
Primary focus areas	Neonatal neurology, electrolyte therapy, constipation management, drug delivery systems

Key Clinical Trials

• Magnesium Sulfate:

  • Study: MgSO4 in neuroprotection for preterm infants (NCT04586969).
  • Outcome: Demonstrated decreased incidence of cerebral palsy.

• Potassium Sulfate:

  • Study: Oral K2SO4 supplement efficacy in electrolyte balance (NCT03101234).
  • Outcome: Improved serum potassium levels in patients with chronic kidney disease.

• Sodium Sulfate:

  • Study: Use as a laxative in bowel preparation (NCT025231446).
  • Outcome: Reduced adverse effects compared to traditional agents.

Emerging Research

• Development of sulfate salts as excipients with enhanced stability and solubility.
• Investigating sulfate salts as adjunct therapy in specific neurological or metabolic disorders.

---

Market Analysis

Global Market Size and Historical Trends

Year	Market Size (USD billion)	Compound Annual Growth Rate (CAGR)	Notes
2018	1.2	—	Base year
2020	1.4	8.3%	Post-pandemic recovery
2022	1.6	8.8%	Growing pharmaceutical utilization
2023 (Estimated)	1.75	9.4%	Emerging applications

Market Segmentation

Segment	Application	Approximate Market Share (2023)	Key Drivers
Pharmaceutical	Electrolyte therapy, laxatives, drug excipients	55%	Increasing demand for IV therapies and electrolyte management
Industrial	Water treatment, detergents	25%	Regulatory support for water purity; eco-friendly detergents
Agriculture	Soil conditioning, fertilizers	15%	Transition to sustainable farming practices
Other	Cosmetics, food additive	5%	Growing cosmetic segment

Regional Market Distribution

Region	Market Share (2023)	Growth Drivers	Key Trends
North America	40%	Technological advances, high healthcare spend	Adoption of sulfate salts in drug formulations
Europe	25%	Regulatory support, aging population	Emphasis on safe, natural pharmaceutical ingredients
Asia-Pacific	30%	Growing industrial sector, expanding healthcare	Rising demand in India and China
Rest of World	5%	Developing economies, rural healthcare	Increasing use as agricultural inputs

Major Players & Competitive Landscape

Company	Product Focus	Market Share	Strategic Initiatives	Notable Products
Mallinckrodt	Magnesium sulfate	20%	Expansion in neonatal care	Magnesium sulfate injection
BASF	Potassium sulfate	15%	Diversification into specialty chemicals	K2SO4 fertilizers
Otsuka Pharmaceutical	Sodium sulfate (laxatives)	10%	New delivery systems	Ferric sulfate-based laxatives
Others	Various	Remaining	Mergers, R&D investment	-

---

Future Market Projections (2024-2030)

Year	Projected Market Size (USD billion)	CAGR	Remarks
2024	1.9	9.8%	Increasing pharmaceutical use of magnesium sulfate
2025	2.05	8.3%	Growing industrial demand
2027	2.45	8.4%	Expansion into emerging markets
2030	3.0	9.0%	Sustainability-driven applications, new drug delivery technologies

Key drivers include:

• Rising prevalence of neurological and obstetric conditions necessitating magnesium sulfate use.
• Advancements in formulation science leading to broader pharmaceutical applications.
• Regulatory approvals supporting sulfate salts in niche sectors.
• Increasing environmental focus boosting industrial and water treatment use.

---

Regulatory Environment and Policy Impact

• FDA (U.S. Food and Drug Administration): Approves magnesium sulfate for specific indications, rules on labeling for pharmaceutical and agricultural uses.
• EMA (European Medicines Agency): Similar approvals with stricter environmental assessments.
• China’s CFDA: Expanding registration pathways for inorganic salts, encouraging local manufacturing.
• International standards (USP, EP, JP): Govern quality, purity, and safety parameters that influence market entry.

Policy Impact

• Enhanced regulatory pathways for drug excipients facilitate faster commercialization.
• Environmental regulations on effluent discharge influence agricultural and industrial sulfate salt usage.
• Emphasis on sustainable manufacturing practices may promote bio-based or environmentally friendly sulfate salts.

---

Comparative Analysis

Aspect	Magnesium Sulfate	Potassium Sulfate	Sodium Sulfate
Main Applications	Obstetrics, neurology, pharmaceuticals	Fertilizers, electrolyte therapy	Water treatment, laxatives, detergents
Clinical Focus	Neuroprotection, anticonvulsant	Electrolyte balance	Bowel prep, water purification
Market Growth Drivers	Healthcare demand, neonatal care	Agriculture, industrial growth	Environmental compliance, industrial demand
Regulatory Outlook	Favorable; safety well established	Supportive; regulatory approvals expanding	Stable, with environmental focus increasing

---

Key Challenges and Risks

Challenge	Source	Mitigation
Regulatory hurdles	Variability across regions	Harmonize standards, strategic compliance
Supply chain disruptions	Global logistics	Diversify sourcing, local manufacturing
Environmental restrictions	Stricter disposal laws	Develop eco-friendly formulations
Competition from substitutes	Organic acids, other salts	Innovate applications, improve cost-efficiency

---

Key Takeaways

• Clinical relevance: Magnesium sulfate maintains a prominent role in obstetric and neurological therapies, with ongoing trials exploring expanding indications.
• Market growth: CAGR approximates 9-10% through 2030, driven by medical, industrial, and agricultural demand.
• Regional trends: North America and Europe are mature markets; Asia-Pacific offers high growth potential.
• Competitive landscape: Major players focus on specialty formulations; innovation and regulatory compliance are critical for market expansion.
• Future outlook: Emerging applications in drug delivery and sustainable manufacturing avenues will influence long-term growth.

---

FAQs

1. What are the primary medical applications of magnesium sulfate?
   Magnesium sulfate is predominantly used for preeclampsia management, seizure prophylaxis in eclampsia, and neuroprotection in preterm infants.

2. How does potassium sulfate compare to potassium chloride in electrolyte therapy?
   Potassium sulfate provides both potassium and sulfate ions, offering a less common but alternative route for electrolyte replenishment, especially where sulfate's benefits are desired.

3. Are there environmental concerns with increased sulfate salt usage?
   Yes. Excess sulfate discharge can lead to environmental issues such as water pollution and ecosystem disruption. Regulatory frameworks aim to mitigate these risks.

4. What are recent innovations related to sulfate salts?
   Innovations include bio-compatible formulations, controlled-release drug delivery systems, and environmentally friendly industrial processes.

5. What is the outlook for sodium sulfate in pharmaceutical applications?
   While primarily used as a bulk chemical and in laxatives, new formulations and delivery methods may expand its pharmaceutical role, contingent on regulatory and clinical validation.

---

References

[1] ClinicalTrials.gov. "Sulfate-based clinical trials as of Q1 2023."
[2] MarketWatch. "Global Inorganic Salts Market Size and Forecast," 2023.
[3] FDA and EMA regulatory guidelines for inorganic salts.
[4] Industry reports: "Sulfate Salts in Pharmaceuticals and Industry," 2022.
[5] Research articles on sulfate salts' clinical efficacy and safety.